(Press-News.org) Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.
These variants increased patients' risk of dying in the year following a first heart attack, but they appeared to do so for different reasons depending on race, according to a study at Washington University School of Medicine in St. Louis.
In particular, the team found that two DNA variants common in African Americans were associated with an increased risk of both bleeding and death. In Caucasians, a different variant was linked to additional heart attacks and a higher risk of death.
The research is published June 17 in the American Heart Association journal Circulation: Cardiovascular Genetics.
The variations influence the way people metabolize clopidogrel and can alter its effectiveness. The blood-thinning drug commonly is prescribed after a heart attack to reduce the likelihood of another heart attack or a stroke.
"The research is provocative," said the study's first author, cardiologist Sharon Cresci, MD, assistant professor of medicine and of genetics. "Knowing about potential genetic differences based on race can help physicians tailor drugs to patients based on their genetic makeup."
Clopidogrel is metabolized in the liver, where it is turned into its active form via a group of enzymes called cytochrome P450, or CYP for short. Although clopidogrel is effective in many patients, earlier studies determined that some people metabolize the drug better than others.
Indeed, in 2010, the Food and Drug Administration added a "black box" warning to labels of clopidogrel after research that primarily involved Caucasians showed that people with a particular CYP genetic variant metabolized the drug poorly, which reduced the amount of the drug circulating in the blood. These patients had a higher risk of heart attack and stroke.
Additional studies showed that other CYP gene variants are linked to the rapid metabolism of clopidogrel and that patients with those variants had a higher risk of bleeding.
But it has not been clear until now that the effects of these particular gene variations can vary by race in patients taking clopidogrel after a heart attack.
For the study, the researchers analyzed CYP variants among 2,062 Caucasians and 670 African Americans who suffered heart attacks. Nearly 80 percent of the Caucasians and 65 percent of the African Americans were prescribed clopidogrel. The patients were enrolled in a major study known as TRIUMPH (Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health) conducted from 2005 to 2008 at 24 U.S. hospitals, including Barnes-Jewish Hospital in St. Louis.
Among patients taking clopidogrel, the one-year mortality rate for African Americans was 7.2 percent, compared with 3.6 percent for Caucasians.
Caucasians who carried the CYP2C19*2 variant, which has been linked to poor metabolism of the drug, had a higher rate of repeat heart attacks and death. The higher rate of heart attacks is consistent with the slower metabolism of clopidogrel.
However, among African Americans treated with clopidogrel, the CYP2C19*2 variant was not associated with a higher rate of death.
Rather, African Americans had higher rates of bleeding and death if they carried either of two other variants: CYP1A2*1C or CYP2C19*17, the latter of which has been associated with the rapid metabolism of clopidogrel. Among Caucasians on clopidogrel, neither variant increased the risk of death.
"This is very novel information that begs for more research," said cardiologist Richard G. Bach, MD, the study's senior author and an associate professor of medicine at Washington University.
Although genetic testing is available to identify CYP variants in a patient's DNA, these tests generally are not widely used by cardiologists. Results of the current study suggest this practice may need to be reconsidered.
"This research is an important addition to the field because previous studies looking at CYP gene variants and their effects on risks of repeat heart attacks, bleeding and death have included predominantly Caucasian patients of European ancestry," Cresci noted. "There is almost no data, until now, about these variants in African Americans."
Research examining how genetic variants alter the effectiveness of clopidogrel remains somewhat controversial, Bach said. Many physicians feel that before they can tailor medical therapy for heart attack patients, more data is needed to prove there is a clear link between genetic variants and negative health consequences and that tailoring therapy will improve patients' outcomes, he explained.
His hope is that additional research would provide more definitive conclusions to help physicians choose the best medications for patients after a heart attack and, ultimately, "to reduce the too-high rate of death and disability for patients after a heart attack," Bach said.
Cresci agreed, adding: "By focusing on genetic differences, we may be able to individualize therapies after heart attacks and achieve the best treatment for each patient."
INFORMATION:
The research is supported by the National Institutes of Health (R01 NR013396). TRIUMPH was sponsored by the National Institutes of Health (Washington University School of Medicine SCCOR Grant P50 HL077113.)
Cresci S, Depta JP, Lenzini PA, Li AY, Lanfear DE, Province MA, Spertus JA and Bach RG. Cytochrome P450 gene variants, race and mortality among clopidogrel-treated patients following acute myocardial infarction. Circulation: Cardiovascular Genetics. In print, June 17, 2014.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Study shows race a factor in mortality in heart attack patients on anti-clotting drug
2014-06-18
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Birds evolve 'signature' patterns to distinguish cuckoo eggs from their own
2014-06-18
For some birds, recognising their own eggs can be a matter of life or death.
In a new study, scientists have shown that many birds affected by the parasitic Common Cuckoo - which lays its lethal offspring in other birds' nests - have evolved distinctive patterns on their eggs in order to distinguish them from those laid by a cuckoo cheat.
The study reveals that these signature patterns provide a powerful defense against cuckoo trickery, helping host birds to reject cuckoo eggs before they hatch and destroy the host's own brood.
To determine how a bird brain might ...
Groundbreaking research finds human sweat can reduce bacteria defenses
2014-06-18
Sweaty hands can reduce the effectiveness of bacteria-fighting brass objects in hospitals and schools after just an hour of coming into contact with them, according to scientists at the University of Leicester.
While copper found in everyday brass items such as door handles and water taps has an antimicrobial effect on bacteria and is widely used to prevent the spread of disease, Dr John Bond OBE from the University of Leicester's Department of Chemistry has discovered that peoples' sweat can, within an hour of contact with the brass, produce sufficient corrosion to ...
No link found between soy food and endometrial cancer risk, say researchers
2014-06-18
Researchers have found no evidence of a protective association between soy food and endometrial cancer risk, says a new study published (18 June) in BJOG: An International Journal of Obstetrics and Gynaecology.
Soy foods are an almost exclusive dietary source of isoflavones, a plant-derived estrogen. Some studies have highlighted their potential cancer protective properties, however, research looking at the link to endometrial cancer has been inconsistent.
The study defined short IPI as time from the immediate preceding birth to subsequent birth of the index pregnancy ...
Shortage of cybersecurity professionals poses risk to national security
2014-06-18
The nationwide shortage of cybersecurity professionals – particularly for positions within the federal government – creates risks for national and homeland security, according to a new study from the RAND Corporation.
Demand for trained cybersecurity professionals who work to protect organizations from cybercrime is high nationwide, but the shortage is particularly severe in the federal government, which does not offer salaries as high as the private sector.
"It's largely a supply-and-demand problem," said Martin Libicki, lead author of the study and senior management ...
Vaccine 'reprograms' pancreatic cancers to respond to immunotherapy
2014-06-18
Researchers at the Johns Hopkins Kimmel Cancer Center have developed and tested a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, essentially reprogramming these intractable cancers and potentially making them vulnerable to immune-based therapies.
In their study described in the June 18 issue of Cancer Immunology Research, the Johns Hopkins team tested the vaccine in 39 people with pancreatic ductal adenocarcinomas (PDAC), the most common form of pancreatic cancer. The disease becomes resistant to standard chemotherapies and is particularly ...
Supplements of calcium and vitamin D may have too much for some older women
2014-06-18
CLEVELAND, Ohio (June 18, 2014)—Calcium and vitamin D are commonly recommended for older women, but the usual supplements may send calcium excretion and blood levels too high for some women, shows a new study published online today in Menopause, the journal of The North American Menopause Society.
This randomized, placebo-controlled trial included 163 older (ages 57 to 90) white women whose vitamin D levels were too low. The women took calcium citrate tablets to meet their recommended intake of 1,200 mg/day, and they took various doses of vitamin D, ranging from 400 to ...
Moral tales with positive outcomes motivate kids to be honest
2014-06-18
A moral story that praises a character's honesty is more effective at getting young children to tell the truth than a story that emphasizes the negative repercussions of lying, according to research published in Psychological Science, a journal of the Association for Psychological Science.
The findings suggest that stories such as "The Boy Who Cried Wolf" and "Pinocchio" may not be effective cautionary tales when it comes to inspiring honest behavior in children.
Stories have long been employed to instill moral and cultural values in young children, but there is little ...
Thieving chimps changing the way African farmers feed their families
2014-06-18
Dublin, June 18th 2014 – Light-fingered chimpanzees are changing the way subsistence farmers make a living in Africa by causing them to grow different crops and spend more time guarding their goods. This is according to work performed by researchers from Trinity College Dublin's School of Geography, who say that communities near the edge of tropical forests are experiencing a lack of 'dietary diversity' and an increased exposure to disease-carrying insects as a result.
Through crop raiding, a form of human-wildlife conflict, hundreds of thousands of marginalised farmers ...
New study suggests benefit of screening on breast cancer deaths
2014-06-18
An accompanying editorial says this study largely confirms what is already known - that the benefits of breast screening "are modest at best" – and calls for women to be given balanced information including the screening harms of overdiagnosis, psychological stress, and high healthcare costs.
Randomised trials from the 1970s and 80s suggested that mammography screening prevents deaths from breast cancer. But the methods used by some of these studies have been criticised, and this has raised doubts about the validity of the findings. Advances in technology and treatment ...
Vitamin D may play an important role in cancer prognosis
2014-06-18
The main source of vitamin D is its production in skin thanks to the sun. Women are more prone to low vitamin D than men - and due to differing weather conditions, concentrations vary in populations across the world.
Vitamin D deficiency is especially common among the elderly who often have less sun exposure, but it is unclear what effect the production of vitamin D has on death.
So researchers investigated the association of vitamin D with deaths from all-causes, cardiovascular diseases and cancer. They paid particular attention to differences between countries, sexes ...